| Original language | English (US) |
|---|---|
| Pages (from-to) | 550 |
| Number of pages | 1 |
| Journal | Journal of Allergy and Clinical Immunology |
| Volume | 127 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 2011 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Reply. / Simon, Michael R.; Chinchilli, Vernon M.; Phillips, Brenda R.; Sorkness, Christine A.; Lemanske, Robert F.; Szefler, Stanley J.; Taussig, Lynn; Bacharier, Leonard B.; Morgan, Wayne.
In: Journal of Allergy and Clinical Immunology, Vol. 127, No. 2, 02.2011, p. 550.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Reply
AU - Simon, Michael R.
AU - Chinchilli, Vernon M.
AU - Phillips, Brenda R.
AU - Sorkness, Christine A.
AU - Lemanske, Robert F.
AU - Szefler, Stanley J.
AU - Taussig, Lynn
AU - Bacharier, Leonard B.
AU - Morgan, Wayne
N1 - Funding Information: Disclosure of potential conflict of interest: V. M. Chinchilli receives research support from the National Institutes of Health . L. B. Bacharier receives honoraria from AstraZeneca and serves on advisory boards for Genentech, GlaxoSmithKline, Merck, Schering-Plough, and Aerocrine. W. Morgan has consultant arrangements with Genentech, Novartis, and the Cystic Fibrosis Foundation ; is a speaker for Phadia AB; and receives research support from the NIH-NHLBI CARE Network and the Cystic Fibrosis Foundation . S. J. Szefler has consultant arrangements with GlaxoSmithKline, Genentech, Merck, Boehringer-Ingelheim, Novartis, and Schering-Plough and receives research support from the NIH/NHLBI Childhood Asthma Management Program, the NIH/NHLBI Childhood Asthma Research and Education, the NIH/NHLBI Asthma Clinical Research Network, the NIH/NIAID Inner City Asthma Consortium, GlaxoSmithKline, the NJH/NHLBI Asthma Net, and the NEEHS/EPA Childhood Environmental Health Center grant. C. A. Sorkness is on advisory boards for GlaxoSmithKline, Schering Plough, and AstraZeneca and receives research support from Schering Plough and Compleware/Sandoz . R. F. Lemanske is a speaker for Merck, AstraZeneca, Doembacher Children's Hospital, Washington University, Medicus Group, Parke Nicolet Institute, ACAAI, LA Allergy Society, Michigan Allergy/Asthma Society, Medical College of Wisconsin, Fund for Medical Research and Education (Detroit), Children's Hospital of Minnesota, Toronto Allergy Society, AAAAI, Beaumont Hospital (Detroit), University of Illinois, Canadian Society of Allergy and Clinical Immunology, New York Presbyterian, Med Media Education Group, Onpointe Medical Communication, Medical University of South Carolina, Health Matters Communication, Bishop McCann, Donohue, Purohit, Miller, Inc, Center for Health Care Education, University of California-San Francisco, American Thoracic Society, University of Iowa, Indiana University, American Lung Association of Upper Midwest, Vanderbilt University, and Rochester Children's Hospital; has consultant arrangements with AstraZeneca, Map Pharmaceuticals, Gray Consulting, Smith Research, Inc, Merck Childhood Asthma Network, Novartis, Quintiles/Innovax, RC Horowitz & Co, Inc, International Meetings and Science, Scienomics, Scientific Therapeutics, and Cognimed, Inc, is an author for Up-to-Date; and is a textbook editor for Elsevier, Inc. The rest of the authors have declared that they have no conflicts of interest.
PY - 2011/2
Y1 - 2011/2
UR - http://www.scopus.com/inward/record.url?scp=79551489238&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79551489238&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2010.10.052
DO - 10.1016/j.jaci.2010.10.052
M3 - Letter
AN - SCOPUS:79551489238
VL - 127
SP - 550
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
SN - 0091-6749
IS - 2
ER -